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Abstract Interest in producing biofuels from renewable
sources has escalated due to energy and environmental
concerns. Recently, the production of higher chain alcohols
from 2-keto acid pathways has shown significant progress.
In this paper, we demonstrate a mutagenesis approach in
developing a strain of Escherichia coli for the production
of 3-methyl-1-butanol by leveraging selective pressure
toward L-leucine biosynthesis and screening for increased
alcohol production. Random mutagenesis and selection
with 4-aza-D,L-leucine, a structural analogue to L-leucine,
resulted in the development of a new strain of E. coli able
to produce 4.4 g/L of 3-methyl-1-butanol. Investigation of
the host’s sensitivity to 3-methyl-1-butanol directed
development of a two-phase fermentation process in which
titers reached 9.5 g/L of 3-methyl-1-butanol with a yield
of 0.11 g/g glucose after 60 h.
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Introduction
Growing concerns with the diminishing reserves, supply
security, and environmental impact of petroleum-based
liquid fuels have intensified efforts to meet these challenges
(Connor and Liao 2009; Dinneen 2008; Stephanopoulos
2007). Biofuels produced from renewable sources have the
potential to mitigate some of these issues. The production
of ethanol, in particular, has steadily risen to 9.2 billion
gallons in 2008 in the USA (Seiferlein 2009), with new
research directed toward using lignocellulosic feedstocks
as a raw material as this would greatly increase the land
yield for production and reduce the dependence of fuel
production on food crops. Bioethanol production is an
attractive option because of the high productivity and yield
during fermentation. Ethanol, however, is limited by its
low energy density (∼70% of gasoline) and hygroscopicity,
making it incompatible with the current infrastructure. In
hopes of addressing some of the shortcomings of ethanol,
potential alternative fuels such as higher chain alcohols
produced through the keto acid pathways (Atsumi et al.
2008a, b;C a n na n dL i a o2008; Connor and Liao 2008;
Shen and Liao 2008; Zhang et al. 2008) or through
engineered and natural fermentative pathways (Atsumi et
al. 2008b; Lee et al. 2008) have been investigated. Higher
chain alcohols (C3–C5), in particular, are attractive fuel
alternatives due to their increased energy density and low
hygroscopicity.
Previously, a metabolic engineering approach was
applied to Escherichia coli for the production of the
potential biofuel 3-methyl-1-butanol (3MB; Connor and
Liao 2008). Metabolic engineering is the practice by which
the development of biological processes is optimized
through genetic and regulatory manipulations. This
approach has been used for many years in the design of
microorganisms for the production of many valuable
metabolites and commodity chemicals and, more recently,
biofuels (Atsumi et al. 2008a, b; Atsumi and Liao 2008;
Kim et al. 2007; Lee et al. 2009; Withers et al. 2007;Y a n
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design in the development of a biocatalyst, although widely
successful, suffers from a few shortcomings, the most
significant being that the metabolic pathway for the
production of the target must be elucidated. For effective
optimization, details on the genes and enzymes responsible
for the synthesis of the target compound, as well as
undesired side products, must be known. Cellular metabo-
lism is very complex and often highly interdependent, and
it is therefore difficult to account for every detail when
designing a strain in this manner. One way to address this
concern is to create a random library of strain variants and
use selective pressure to discover strains with the desired
phenotype. The use of selective pressure can allow for
investigation on the order of 10
9–10
12 strains, which would
not be possible otherwise. This procedure can also be used
iteratively to develop strains with increasingly desirable
phenotypes. The difficulty in using this strategy is the
development of a selection as this is not possible for every
process. However, because the production of 3MB uses the
2-keto acid pathways, the development of a new strain can
be greatly aided by the vast knowledge and technology base
in amino acid production.
A powerful tool used in the development of amino acid
production strains is random mutagenesis and selection
with an amino acid analogue (Ikeda 2003). Chemical
mutagens such as N-methyl-N′-nitro-N-nitrosoguanidine
(NTG) or ethyl methanesulfonate are often used to create
genome-wide mutations, with NTG being the more popular
choice due to its superior mutation rate. Selection pressure
in this case is provided by the toxicity of amino acid
analogues. This toxicity could be due to several effects,
including interference in the regulation of amino acid
biosynthesis and incorporation into polypeptides. Among
the means with which a cell can adapt to survive the
challenge of the analogue is the ability to produce the
natural amino acid in high enough quantities to outcompete
the analogue for incorporation into growing polypep-
tides. Because this is not the only reason a cell can gain
resistance to an analogue, variant strains which show an
increased resistance to the amino acid analogue must
then be screened and verified for the desired phenotype
before being subjected to additional rounds of mutagenesis, if
so desired. The advantage of this strategy is that the
nearly infinite possibility of created phenotypes can
effectively be studied because a selective strategy is
being used. This strategy was applied to the production
of 3MB which exploits the L-leucine biosynthesis
pathway (Fig. 1). Here, we demonstrate the development
of a strain of E. coli for the production of 3MB by
subjecting a wild-type strain to mutagenesis by NTG and
challenging these cells with 4-aza-D,L-leucine (AZL), a
structural analogue to natural L-leucine (Table 1).
Materials and methods
Bacteria strains, media, and growth conditions JCL16 (rrnBT14
ΔlacZWJ16 hsdR514 ΔaraBADAH33 ΔrhaBADLD78/F′
[traD36, proAB+, lacIq ZΔM15]) was used as wild type
(WT; Table 2).
To compare JCL16, AL1, and AL2 (Table 2), strains
were grown in M9 medium (6 g Na2HPO4,3gK H 2PO4,
1gN H 4Cl, 0.5 g NaCl, 1 mM MgSO4, 1 mM CaCl2,
10 mg vitamin B1 per liter of water) containing 40 g/L of
glucose, 5 g/L of yeast extract, and 1000X A5 trace metals
m i x( 2 . 8 6gH 3BO3,1 . 8 1gM n C l 2⋅4H2O, 0.222 g
ZnSO4⋅7H2O, 0.39 g Na2MoO4⋅2H2O, 0.079 g
CuSO4⋅5H2O, and 49.4 mg Co(NO3)2⋅6H2O per liter water).
From a 3 mL Luria–Bertani (LB) overnight, cultures were
inoculated 1% by volume (v/v) into 20 mL of fresh medium
in 250-mL screw cap flasks and grown at 37°C in a rotary
shaker until the OD600 reached 0.4–0.8. The culture was then
induced with 1 mM isopropyl-β-D-thiogalactopyranoside
(IPTG) and grown at 30°C for the remainder of the
experiment. Antibiotics were added to all cultures (ampicillin
100 μg/mL, chloroamphenicol 35 μg/mL, and kanamycin
50 μg/mL).
For production experiments with AL2, 3 mL LB
overnight cultures were used to inoculate 10 mL (1%, v/v)
of M9 medium containing 85 g/L of glucose, 10 g/L of
yeast extract, and 1000X A5 trace metals mix and were
inoculated 1% from a 3 mL LB overnight into a 250-mL
screw cap flask. Ten milliliters of oleyl alcohol was added
to flasks prior to incubation for extraction experiments.
Cultures were grown at 37°C in a rotary shaker until the
OD600 reached 0.4–0.8 and were then induced with 1 mM
IPTG and incubated at 30°C in a rotary shaker. For
extraction experiments, equal volumes of the oil and
aqueous layers were always sampled to maintain the
volume ratio. Antibiotics were added to all cultures
(ampicillin 100 μg/mL, chloroamphenicol 35 μg/mL, and
kanamycin 50 μg/mL).
To determine the viable cell count of AL2 after exposure to
3MB, a 3 mL LB overnight was used to inoculate 100 mL
(1%,v/v) of M9 medium containing 85 g/L of glucose, 10 g/L
of yeast extract, and 1000X A5 trace metals mix into two
500-mL baffled shake flasks (50 mL each). Cultures were
grown at 30°C in a rotary shaker until the OD600 was 0.4–0.8
and then split into 15-mL screw cap tubes containing 4 mL
each. 3MB was then added to the tubes in various
concentrations and incubated at 30°C in a rotary shaker. Each
3MB concentration was tested in duplicate tubes. Samples
w e r et a k e na t8a n d2 4hi nw h i c hc u l t u r e sw e r ed i l u t e di n
triplicate between 10
−5 and 10
−6 a n dp l a t e do nL Ba g a rp l a t e s
and incubated overnight at 37°C. The viable cell count was
measured by counting the colony forming units (CFU) on
each plate and normalizing it to the control (0 g/L 3MB).
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Aldrich (St. Louis, MO, USA). Alcohol standards were
purchased from Fisher Scientific (Pittsburgh, PA, USA)
and Sigma-Aldrich. Oleyl alcohol was purchased from
Sigma-Aldrich. High-performance liquid chromatography
(HPLC) grade heptane was purchased from Fisher
Scientific.
Mutagenesis,selection,andscreeningofmutant libraries The
protocol for NTG mutagenesis was adapted from the
method of Miller (1972). From 3 mL LB overnight cultures
of the parental strains (JCL16, AL1), cultures were
inoculated 1% (v/v) into 5 mL of fresh LB medium and
grown at 37°C in a rotary shaker until the OD600 reached
0.4–0.6. Cells were spun down at room temperature and
washed with an equal volume 0.1 M Na citrate (pH 5.5)
twice before resuspending the cells in half the original
volume of 0.1 M Na citrate. NTG was added to a final
concentration of 50 μg/mL from a 1 mg/mL stock in 0.1 M
Na citrate and incubated at 37°C for 15 min. For the control
experiment, an equal volume of 0.1 M Na citrate was added
instead of NTG and incubated at 37°C for 15 min. After
incubation, cells were washed twice with the original
volume of 0.1 M phosphate buffer (pH 7.1). The cells were
then resuspended in 5 mL of LB and incubated at 37°C
overnight for outgrowth. A small amount of cells were plated
for both the NTG-treated tube and the control tube on LB
plates to determine the kill count for the experiment before
outgrowth (Table 3). After outgrowth overnight, cultures
were spun down and resuspended in 0.1 M phosphate buffer
(pH 7.1) and plated on M9 plates containing 10 g/L of
glucose, 1000X A5 trace metals, and 2 g/L (JCL16
mutagenesis) or 8 g/L (AL1 mutagenesis) of AZL and
incubated at 37°C for 2–3d a y s .
Mutant colonies resistant to AZL were then re-streaked on
identical plates to assure a stable phenotype. Colonies with
this stable phenotype were then picked and used to inoculate
400 μL of M9 medium containing 10 g/L of glucose, 1000X
A5 trace metals, and 1 g/L (JCL16 mutagenesis) or 6 g/L
(AL1 mutagenesis) of AZL in 96-deep-well plates (Corning
Inc., Corning, NY, USA). Plates were quantified for growth
after 24 h of incubation at 37°C in a rotary shaker.
Mutant strains showing increased growth were then
transformed with pIAA12 (Table 2) to screen for 3MB
production. 3 mL LB overnight cultures of transformant
strains were used to inoculate 10 mL (1%, v/v)o fM 9
medium containing 10 g/L of glucose, 5 g/L of yeast
extract, and 1000X A5 trace metals in a 125-mL screw cap
flask and incubated at 37°C in a rotary shaker until the
OD600 was 0.4–0.8. Cultures were then induced with 1 mM
IPTG and incubated at 30°C in a rotary shaker and sampled
at 24 h for growth and alcohol production. Ampicillin
(100 μg/mL) was added to all cultures.
Variant strains showing increased production of 3MB
relative to the parental strain were then transformed with
pIAA11, pIAA13, and pIAA16 (Table 2). Three milliliters
Glucose
G6P Ru5P
F6P
F6P E4P
G3P
3PG
PEP
Pyruvate Acetyl-CoA
OAA
α-KG
L-Phenylalanine
L-Trytophan
L-Tyrosine
L-Cysteine
L-Glycine
L-Serine
L-Aspartate
L-Asparagine
L-Isoleucine
L-Lysine
L-Methionine
L-Threonine
L-Arginine
L-Glutamate
L-Glutamine
L-Proline
2-ketoisovalerate
L-Alanine
L-Valine
2-ketoisocaproate
L-Leucine
3MB
L-Histidine R5P
alsS (BS)
ilvCD
leuA (G462D)
leuBCD
kivd (LL)
ADH2 (SC)
Fig. 1 Metabolic pathway
for amino acid biosynthesis and
3-methyl-1-butanol production.
All genes are from E. coli unless
otherwise noted. BS B. subtilis,
LL L. lactis, SC S. cerevisiae
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20 mL (1%, v/v) of M9 medium containing 30 g/L of
glucose, 5 g/L of yeast extract, and 1000X A5 trace metals
in a 250-mL screw cap flask and incubated at 37°C in a
rotary shaker until the OD600 reached 0.4–0.8. Cultures
were induced with 1 mM IPTG and incubated at 30°C in a
rotary shaker and sampled at 24 and 48 h for growth and
alcohol production. Antibiotics were added to all cultures
Table 1 Common analogues for branched-chain amino acids
Alcohol Amino Acid Analogue
1-propanol L-threonine α-amino-β-hydroxyvaleric acid
(S)-2-methyl-1-butanol L-isoleucine D,L-4-thiaisoleucine
α-aminobutyric acid
D,L-norvaline
5,5,5-trifluoroleucine
4-aza-D,L-leucine
Isobutanol L-valine
3-methyl-1-butanol L-leucine
OH
OH
OH
OH
O
OH
OH
NH2
O
OH
NH2
O
OH
NH2
O
OH
NH2
O
OH
NH2
OH
O
OH
NH2
S
O
OH
NH2
O
OH
NH2
O
OH N
NH2
CF3
O
OH
NH2
Table 2 Strains and plasmids used in this study
Name Relevant genotype Reference
Strains
JCL16 BW25113/F′ [traD36, proAB+, lacIq ZΔM15] Atsumi et al. 2008b
AL1 NTG-created mutant from JCL16 This Study
AL2 NTG-created mutant from AL1 This study
Plasmids
pIAA11 pSC101; Kan
R ;P LlacO-1: alsS (BS)–ilvCD (EC) Connor and Liao 2008
pIAA12 ColE1 ; Amp
R;P LlacO-1: kivd (LL)–ADH2 (SC) ; PAmp: bla-lacI (EC) Connor and Liao 2008
pIAA13 p15A ; Amp
R;P LlacO-1: kivd (LL)–ADH2 (SC) Connor and Liao 2008
pIAA16 ColE1 ; Cm
R;P LlacO-1: leuA(G462D) (EC)–leuBCD (EC); PCm: cat-lacI (EC) Connor and Liao 2008
BS B. subtilis, EC E. coli, LL L. lactis, SC S. cerevisiae
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kanamycin 50 μg/mL).
Detection of metabolites The produced alcohol compounds
were quantified by a gas chromatograph (GC) equipped
with a flame ionization detector. The system consisted of
model 5890A GC (Hewlett Packard, Avondale, PA, USA)
and a model 7673A automatic injector, sampler, and
controller (Hewlett Packard). The separation of alcohol
compounds was carried out by a DB-WAX capillary
column (60 m, 0.32-mm i.d., 0.50-μm film thickness)
purchased from Agilent Technologies (Santa Clara, CA,
USA). GC oven temperature started at 40°C and was raised
with a gradient of 5°C/min until 80°C and held for 2 min. It
was then raised with a gradient of 45°C/min until 125°C
and held for 2 min. The oven temperature was then raised at
a rate of 60°C/min until 235°C and held for 5 min. Helium
was used as the carrier gas with 25-psi inlet pressure. The
injector and detector were maintained at 225°C. For
aqueous samples, 0.5 μL of culture broth supernatant was
injected in split injection mode. For oleyl alcohol samples,
samples were diluted with HPLC grade heptane in a 1:1
ratio to reduce the viscosity and increase the accuracy of
injection. Glucose was quantified using a YSI 2700
SELECT Biochemistry Analyzer (YSI Life Sciences,
Yellow Springs, OH, USA).
Results
Mutagenesis with NTG and selection with AZL A schematic
for the mutagenesis and selection/screening process is
diagrammed in Fig. 2. In order to develop a new strain
for the hyperproduction of 3MB, E. coli strain JCL16
(Table 2) was treated with NTG (see “Materials and
methods”) and plated on minimal medium plates containing
glucose (10 g/L) and AZL (2–8 g/L). Mutants displaying
resistance to AZL were re-streaked on the same minimal
medium plates to validate the phenotype. Resistant strains
were then screened for growth in liquid minimal medium
containing AZL. Growth was quantified after 24 h, and
strains able to grow to a higher cell density were selected
for transformation with kivd (Lactococcus lactis) and ADH2
(Saccharomyces cerevisiae) expressed from PL-lacO1
(pIAA12; Table 2). The production of 3MB from each of
these strains was quantified after 24 h, and the strains able
toproduce the highest amountof3MB werechosenfor a final
round of screening in which each of these strains was tested
for 3MB production after overexpression of all the genes
involved in the 3MB production pathway, including alsS
(Bacillus subtilis), ilvCD (E. coli), leuA(G462D)( E. coli;
Gusyatiner et al. 2002), and leuBCD (E. coli). These genes
were all expressed from PL-lacO1 (pIAA11, pIAA16) along
with kivd and ADH2 (pIAA13; Table 2). 3MB was
quantified after 24 and 48 h, and the mutant that produced
the greatest amount of 3MB was chosen for further
analysis.
Mutagenesis results After the first round of mutagenesis
and selection with 2 g/L of AZL, a total of 128 resistant
colonies were isolated and re-streaked. Of these 128 variant
strains, 21 were able to grow to at least OD600=0.4 after
24 h in minimal medium in the presence of 1 g/L of AZL as
cells showed an increased sensitivity to the analogue in
liquid medium compared to solid medium. These mutants
were transformed with kivd and ADH2 (pIAA12) and
assayed for 3MB production. Five mutants displayed a
significant increase in 3MB production relative to parental
strain (120 mg/L), and after transformation with the entire
3MB production pathway in these mutants, strain JCL16
NTG M8, named AL1, was able to produce nearly double
the 3MB (0.75 g/L) as that of the WT (0.43 g/L). AL1 was
then selected as the parent for the next round of
mutagenesis. AL1 was treated with NTG as before and
selection was carried out in the presence of 8 g/L of AZL.
After the second round of mutagenesis, 64 colonies
resistant to 8 g/L of AZL on solid medium were screened
for growth in liquid media with 6 g/L of AZL, out of which
12 showed superior growth (OD600>0.25). Six mutants
outperformed the parent upon transformation of kivd and
ADH2 and were chosen for transformation with the entire
3MB pathway. Strain JCL16 NTG M8-C2, designated AL2,
was able to produce a significantly higher amount (1.5 g/L)
of 3MB of that AL1 after 24 h. AL2 was the only mutant
from the second round to show an increase in 3MB
production under this condition.
AL2wasthenchosenasthe parentforfurthermutagenesis.
However, several attempts to generate a better host for 3MB
productionwereunsuccessful.StrainAL2was thencompared
with AL1 and JCL16 for growth, glucose consumption, and
alcohol production (Fig. 3). Growth for each strain was
similar, as was isobutanol production. AL1 was able to
produce twice (1.1 g/L) the 3MB after 72 h as that of JCL16
Mutation statistics Round 1 Round 2
Kill count
#of NTGtreatedsurvivorsðLBÞ
#of NTGcontrolsurvivorsðLBÞ   100% 61.54% 21.47%
Frequency of mutation
#of NTGtreatedmutantsðM9þAnalogueÞ
#of NTGtreatedsurvivorsðLBÞ 6.4×10
−5 1.2×10
−5
Table 3 Mutagenesis statistics
for development of AL1 and
AL2
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Fig. 2 Diagram for mutagenesis/screening scheme. Cells are exposed to
N-methyl-N′-nitro-N-nitrosoguanidine and selected for resistance to
4-aza-D,L-leucine on minimal media plates. Resistant colonies are
screened for growth in liquid medium in 96-well plates (3), and assayed
for 3MB production with kivd and ADH2 (5). Mutants showing an
increase in production of 3MB are then assayed for production of 3MB
with the entire pathway of genes (7). The highest producing mutant from
this group is chosen as the parent for the next round of mutagenesis
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Fig. 3 Mutantstraincomparison.
Growth, glucose consumption,
and alcohol production was
quantified in JCL16 (parent),
AL1 (first round mutant), and
AL2 (second round mutant)
during fermentation in shake
flasks. Each strain harbored
plasmids pIAA11 (alsS–ilvCD)
pIAA13 (kivd–ADH2), and
pIAA16 (leuA
(G462D)–leuBCD)
1160 Appl Microbiol Biotechnol (2010) 86:1155–1164(0.45 g/L) at a significantly higher yield (0.08 to 0.04 g/g
after 36 h). AL2, however, showed a significant increase in
glucose consumption and 3MB production relative to both
strains. AL2 was able to produce 2.8 g/L of 3MB after 36 h
at a yield of 0.11 g/g, which is significantly higher than
either parental strains in terms of final product titer and yield.
After 36 h, however, glucose consumption and 3MB
production declined significantly.
3MB production and tolerance in AL2 We hypothesized
that the cessation of glucose consumption and 3MB
production in AL2 could be due to (1) growth/medium
conditions or (2) toxicity of the endogenously produced
alcohol. The first hypothesis was tested using a richer
medium (85 g/L glucose and 10 g/L yeast extract) to
increase growth and maintaining the pH at 7 by the addition
of 10 M NH4OH as needed. The use of this medium
increased growth significantly, as the OD600 was able to
reach nearly 10 after just 24 h, compared to the previous
high of 4.5. The pH also required constant adjustment and
would decrease by ∼1 unit every 12 h. After 36 h,
production reached 4.4 g/L with a yield of 0.10 g/g
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Fig. 4 Production of 3MB in
AL2. a Growth, glucose
consumption, and alcohol
production of AL2 (second
round mutant) harboring
plasmids pIAA11 (alsS–ilvCD),
pIAA13 (kivd–ADH2), and
pIAA16 (leuA (G462D)–
leuBCD) was quantified during
fermentation in shake flasks.
Filled triangles represent the
total 3MB production in AL2
fermentations containing oleyl
alcohol for in situ extraction,
and open triangles represent the
control AL2 fermentations
without oleyl alcohol. b Distri-
bution of 3MB and isobutanol in
oleyl alcohol fermentations.
Filled bars represent the alcohol
concentration in the aqueous
culture, and open bars represent
the alcohol concentration in the
oleyl alcohol layer
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as before, the consumption of glucose and production of
3MB declined shortly after. Next, we began to examine the
second hypothesis by testing the sensitivity of AL2 to
exogenously added 3MB. Various concentrations of 3MB
(between 0 and 5 g/L) were added to cultures of AL2, and
the cell viability was measured by counting the number of
CFU at 8- and 24-h intervals. A significant growth
deficiency was observed at 3MB concentrations as low as
1 g/L (Fig. 5), with severe effects starting at 3 g/L (<17%
viability). At 5 g/L, the cell viability was less than 0.1%
(Fig. 5). As expected, the toxicity of 3MB is far greater
than that of alcohols with a shorter alkyl chain. This finding
has previously been demonstrated with 1-butanol and
isobutanol in which the tolerance to each of these alcohols
is below 16 g/L (Atsumi et al. 2008a; Knoshaug and Zhang
2009), which is significantly lower than that of ethanol
(∼50 g/L).
Two-phase fermentation Theseresultssupportthehypothesis
thatproductionof3MBinAL2islimitedbythetoxicityofthe
alcohol as the cell viability at 4.4 g/L is less than 4%. To
further examine this hypothesis, we employed a two-phase
fermentation system to continuously remove the 3MB from
the aqueous cellular environment. It has been shown
previously that oleyl alcohol is an effective solvent for the
extraction of 1-butanol during fermentation in Clostridium
acetobutylicum (Roffler et al. 1987). Therefore, a volume of
oleylalcoholwasaddedtotheshakeflasksequaltotheculture
volume at the start of fermentation, creating a two-phase
system. Under these conditions, both the cell density and the
glucose consumption were significantly higher than the
control without oleyl alcohol, and the production of 3MB
was able to reach 9.5 g/L after 60 h (Fig. 4a), which is the
highest production of any C5 alcohol yet reported in
literature. The total yield for 3MB production from glucose
was 0.11 g/g. Total alcohol production reached 12.5 g/L,
which corresponds to a yield of 0.14 g/g from glucose.
Further examination shows that an average of nearly 90% of
the total 3MB produced is contained in the oleyl alcohol
layer (Fig. 4b). The maximum concentration of 3MB in the
aqueous phase reached only 0.8 g/L, at which the cell
viability is greater than 70% (Fig. 5). The oleyl alcohol was
also able to extract an average of over 81% of the total
isobutanol produced, demonstrating that this may be an
effective strategy for the extraction of other higher chain
alcohols. These results clearly demonstrate that the
production of 3MB in AL2 greatly benefits from using
a continuous extractive process as the toxicity barrier can
be avoided to significantly increase production levels to
greater than 5 g/L.
Discussion
A major advantage in the engineering of higher chain
alcohol production is the implementation of existing amino
acid technologies for process improvement. Of these many
technologies, random whole cell mutagenesis and selection
with amino acid analogues (Table 1), in particular, has been
widely used to develop biocatalysts for the production of
many amino acids such as L-threonine, L-isoleucine,
L-valine, and L-leucine among many others (Ikeda 2003).
Here, we applied this strategy for the development of a strain
of E. coli for the production of 3-methyl-1-butanol by
selecting for resistance to a L-leucine analogue and screening
for increased 3MB production. This strategy is advantageous
over rational engineering approaches in that it requires
minimal knowledge of the metabolic pathway, and because
selective pressure is being used, a large library of mutants
can be generated to cover a much more significant portion of
sequence space to generate the desired phenotype. Two
successive rounds of mutagenesis and selection with AZL
resulted in a strain (AL2) able to produce 4.4 g/L of 3MB.
This strategy of random mutagenesis and selection can also
be used to develop strains for the production of other higher
chain alcohols such as isobutanol (L-valine), 1-propanol
(L-threonine), 2-methyl-1-butanol (L-isoleucine), and phenyl-
ethanol (L-phenylalanine). Furthermore, many of these
processes can be challenged with several different analogues
insuccession,resultinginsuperiorproductivity,asoftentimes,
many different structural analogues are available for a single
amino acid (Table 1). This is also applicable in cases where
other amino acids serve as precursors to the final amino acid
of interest. For example, 2-methyl-1-butanol is synthesized
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Fig. 5 Analysisofhosttoleranceto3MB.ViablecellcountsofAL2after
exposure to 3MB for 8 and 24 h. Experiments were done with duplicate
tubes and triplicate plates and normalized to the control (0 g/L 3MB)
1162 Appl Microbiol Biotechnol (2010) 86:1155–1164from an L-isoleucine precursor which itself is synthesized
from L-threonine. Therefore, a strain can be developed using
structural analogues for both L-threonine (α-amino-β-
hydroxyvaleric acid) and L-isoleucine (D,L-4-thiaisoleucine;
Table 1).
Analysis of the host tolerance to 3MB revealed that the
productivity in this strain may be limited by the host’s
sensitivity to the product. The viability of AL2 at 4.4 g/L of
3MB was found to be less than 4%, suggesting that the
toxicity of the product is limiting its own production and
growth. A two-phase fermentationwith oleyl alcohol allowed
for a prolonged production phase in which 3MB was able to
reach a total of 9.5 g/L after 60 h with a yield of 0.11 g/g, with
nearly 90% of the 3MB contained within the oleyl alcohol.
The yield of this experiment is 33% of the theoretical
maximum (0.33 g/g), which is calculated from a stoichiomet-
ric balance from glucose to 3MB under the assumption that
excess reducing power in the form of NAD(P)H can be
recycled to NAD(P)
+ by O2. Total alcohol production
reached 12.5 g/L. The success of this approach increases
the potential of producing 3MB as a biofuel from E. coli as
titers can potentially reach in excess of 30 g/L before the
aqueous concentration of 3MB again becomes troublesome.
This work also demonstrates the utility and potential in
using E. coli as a host for biofuel production. The
accumulated wealth of knowledge and developed genetic
tools, as well as previous successes in pathway engineering
and metabolite production (Chao et al. 1993; Farmer and
Liao 2001; Martin et al. 2003)a sw e l la sa m i n oa c i d
production (Ikeda 2003), make E. coli an attractive host for
higher chain alcohol production via the 2-keto acid pathways.
As production titers continue to increase, existing tools and
technology for product removal (Roffler et al. 1987)a n d
increasing host solvent tolerance (Alper et al. 2006;A t s u m ie t
al. 2008a; Borden and Papoutsakis 2007;Y o m a n oe ta l .
1998), along with the elucidation of solvent response path-
ways (Brynildsen and Liao 2009; Tomas et al. 2004), can be
applied to maintain the development of these processes.
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